Patient Rating:

No Rating Available?

Camille M. Fung, M.D.

Patient Rating:

No Rating Available?

Specialties

Languages

  • Cantonese
  • English

Clinical Details

Phone Number Clinical Office Address
(801) 507-7000
Intermountain Medical Center
5121 Cottonwood Street
Murray, UT 84107
(801) 662-4100
Primary Children's Hospital
Newborn Intensive Care Unit
100 N Mario Capecchi Drive
Salt Lake City, UT 84113
(801) 581-2745
University Hospital
Newborn Intensive Care Unit
50 N Medical Dr
Salt Lake City, UT 84132
Map

Specialties

Bio

Camille Fung, MD is an Assistant Professor in the Division of Neonatology, Department of Pediatrics at the University of Utah, School of Medicine. In addition to caring for sick newborns who require intensive care in 3 different NICUs in the Salt Lake valley, she has a basic science research interest in looking at the effects of perinatal insults such as intrauterine growth restriction (IUGR) on hippocampal neuronal development. This is important because IUGR infants are at increased risk for neurocognitive delays particularly affecting learning and memory, functions that are carried out by the hippocampus, but the underlying mechanisms leading to such delays remain elusive. She uses a mouse model of IUGR that she developed, which mimicks human pregnancy-induced hypertension, to study embyronic and postnatal hippocampal neurogenesis and development. In addition to IUGR's effects on the central nervous system, she has collabrations both within and outside of the University of Utah investigating the mechanisms of IUGR-induced retinopathy, metabolic syndrome, necrotizing enterocolitis, and chronic lung disease/pulmonary hypertension. Relating to her basic science interest, she has quality improvement and clinical research interests on neonatal abstinence syndrome (NAS) management. The incidence of NAS has skyrocketed across the U.S., attributed to prescription opioid misuse and abuse. She has worked closely with interdisciplinary teams both at Intermountain and University Healthcare systems to implement a care process model on NAS management. Working with the Utah Department of Health, she is extending this care process model to other healthcare systems across Utah such that we have a standardized practice on all infants suffering from NAS. She is also a principal investigator on a multi-center clinical trial initiated by Stanford University to use ondansetron as a medication to prevent/curb NAS symptoms. Enrollment of mother-infant pairs is ongoing. Lastly, recognizing the misuse and abuse of prescription opioids, the Utah Division of Professional Licensing passed a mandate that all licensed practitioners who have the ability to prescribe opioids to take a 4-hour educational session on responsible prescribing practice. Dr. Fung, working closely with the University CME office, has been the course director who planned and implemented the curriculum entitled, "Opioid use in pregnant mothers and newborns: what obstetricians and pediatricians should know". Both live presentations and now a web-based version of this course can be accessed by all interested practitioners.

Board Certification and Academic Information

Academic Departments Pediatrics - Assistant Professor
Academic Divisions Neonatology
Board Certification American Board of Pediatrics (Sub: Neo-Peri)
American Board of Pediatrics (Pediatrics)

Academic Profile

Research Interests

  • Neurogenesis
  • Placental Insufficiency
  • Neonatal Abstinence Syndrome
  • Epigenetics
  • Intrauterine Growth Restriction
  • Hippocampal Development

Board Certification and Academic Information

Academic Departments Pediatrics - Assistant Professor
Academic Divisions Neonatology
Board Certification American Board of Pediatrics (Sub: Neo-Peri)
American Board of Pediatrics (Pediatrics)

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 581-7052 Williams Building
University Health Care - Pediatrics Neonatology
295 Chipeta Way
Salt Lake City, UT 84108

Academic Bio

Camille Fung, MD is an Assistant Professor in the Division of Neonatology, Department of Pediatrics at the University of Utah, School of Medicine. In addition to caring for sick newborns who require intensive care in 3 different NICUs in the Salt Lake valley, she has a basic science research interest in looking at the effects of perinatal insults such as intrauterine growth restriction (IUGR) on hippocampal neuronal development. This is important because IUGR infants are at increased risk for neurocognitive delays particularly affecting learning and memory, functions that are carried out by the hippocampus, but the underlying mechanisms leading to such delays remain elusive. She uses a mouse model of IUGR that she developed, which mimicks human pregnancy-induced hypertension, to study embyronic and postnatal hippocampal neurogenesis and development. In addition to IUGR's effects on the central nervous system, she has collabrations both within and outside of the University of Utah investigating the mechanisms of IUGR-induced retinopathy, metabolic syndrome, necrotizing enterocolitis, and chronic lung disease/pulmonary hypertension. Relating to her basic science interest, she has quality improvement and clinical research interests on neonatal abstinence syndrome (NAS) management. The incidence of NAS has skyrocketed across the U.S., attributed to prescription opioid misuse and abuse. She has worked closely with interdisciplinary teams both at Intermountain and University Healthcare systems to implement a care process model on NAS management. Working with the Utah Department of Health, she is extending this care process model to other healthcare systems across Utah such that we have a standardized practice on all infants suffering from NAS. She is also a principal investigator on a multi-center clinical trial initiated by Stanford University to use ondansetron as a medication to prevent/curb NAS symptoms. Enrollment of mother-infant pairs is ongoing. Lastly, recognizing the misuse and abuse of prescription opioids, the Utah Division of Professional Licensing passed a mandate that all licensed practitioners who have the ability to prescribe opioids to take a 4-hour educational session on responsible prescribing practice. Dr. Fung, working closely with the University CME office, has been the course director who planned and implemented the curriculum entitled, "Opioid use in pregnant mothers and newborns: what obstetricians and pediatricians should know". Both live presentations and now a web-based version of this course can be accessed by all interested practitioners.

Research Statement

Dr. Fung's research focuses on how perinatal insults such as intrauterine growth restriction (IUGR) affects hippocampal progenitor cell proliferation and neuronal differentiation to cause an altered neuronal composition in the neonatal and adult brain. Using her own mouse model of IUGR imposed on different reporter mice, they are delineating the time course of hippocampal dentate gyrus neuronal development as well as investigating the molecular mechanisms behind altered proliferation and differentiation. Understanding the mechanism(s) behind altered cell fate may provide a means for future therapeutic interventions to ameliorate neurocognitive delays in IUGR infants.

Education

Education History

Type School Degree
Fellowship UCLA Mattel Children's Hospital
Neonatology
Clinical Fellow
Research Fellow UCLA David Geffen School of Medicine
Developmental Biology
Postdoctoral Research Fellow
Residency St. Christopher's Hosp. for Children
Pediatrics
Resident
Internship St. Christopher's Hospital for Children
Pediatrics
Intern
Professional Medical Jefferson Medical College
M.D.
Graduate Training University of San Francisco
Graduate level Cell Physiology
Undergraduate Santa Clara University
Biology and Chemistry minor
B.S.

Publications

Selected Provider Publications

Clinical Trials

Video & News